Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC

NCT03965468 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

96

Enrollment

NETWORK

Sponsor class

Conditions

Non-small Cell Lung Cancer
Stage IV
Oligometastasis

Interventions

DRUG: Durvalumab
DRUG: Carboplatin
DRUG: Paclitaxel
RADIATION: Stereotactic body radiation therapy (SBRT)
PROCEDURE: Surgical resection - definitive local treatment.
RADIATION: Radical radiotherapy - definitive local treatment.
DRUG: Tremelimumab

Sponsor

ETOP IBCSG Partners Foundation

Collaborators

[object Object]